Information was received from a healthcare provider regarding a patient who was implanted with an implantable neurostimulator (ins) for gastrointestinal/pelvic floor therapy.It was reported that at some point they found that the lead was not in the correct location and a couple months ago the patient was scheduled to replace one of the components but that was not completed.The caller stated that the patient is ill, has had multiple hospitalizations, and is cognitively impaired.The caller indicated that they wanted a rep to turn off the ins because the ins was impeding the callers ability to treat the patient.When asked for a managing doctor, the caller stated that the phone number for the emergency doctor on the patient's id card was disconnected.Troubleshooting was not required.The issue was not resolved through troubleshooting.Agent transferred the caller to nas.
|
Continuation of d10: product id 3889-28.Lot# va0vhzp.Implanted: (b)(6) 2015.Product type lead section d information references the main component of the system.Other relevant device(s) are: product id: 3889-28, serial/lot #: (b)(6), ubd: 11-may-2019, udi#: (b)(4).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|